METHODS: A patient who had Robert\'s uterus with adenomyosis was admitted to our hospital in December 2022. We analyzed and summarized her case .
RESULTS: Our patient complained of progressively worsening primary dysmenorrhea over the course of 3 years and lower abdominal pain lasting for 2 days. Her carbohydrate antigen 125 (CA125) level was 372.10 U/mL. Examinations conducted by several hospitals indicated that she had a single-horned uterus and a residual horned uterus, and our hospital\'s examination identified Robert\'s uterus. This malformation was corrected by open abdominal surgery. For the procedure, pelvic adhesions were first isolated, after which the closed uterine cavity and adenomyosis were resected. Subsequently, the left ovarian endometriosis cyst was resected and right tubal ligation was performed. After surgery, three injections of gonadotropin-releasing hormone A (GnRH-A) were administered, which lowered the patient\'s CA125 level to 14 U/mL and normalized her condition.
CONCLUSIONS: We pioneered a new therapeutic approach for the treatment of Robert\'s uterus with adenomyosis. Some valuable references are provided for clinical practice.
方法:2022年12月,我院收治了一名患有子宫腺肌病的患者。我们对她的案例进行了分析和总结。
结果:我们的患者主诉原发性痛经在3年内逐渐恶化,下腹痛持续2天。她的糖抗原125(CA125)水平为372.10U/mL。多家医院进行的检查表明,她有单角子宫和残角子宫,我们医院的检查确定了罗伯特的子宫。通过开腹手术纠正了这种畸形。对于程序,首先分离出盆腔粘连,然后切除闭合的子宫腔和子宫腺肌病。随后,切除左侧卵巢子宫内膜异位症囊肿,并进行右侧输卵管结扎术。手术后,3次注射促性腺激素释放激素A(GnRH-A),将患者的CA125水平降低至14U/mL,并使她的病情恢复正常。
结论:我们开创了一种新的治疗方法,用于治疗子宫腺肌病。为临床实践提供了一些有价值的参考。